Gegenanzeigen · Zomarist
Zomarist 50 mg/850 mg film-coated tablets Zomarist 50 mg/1000 mg film-coated tablets · Abschnitt 4.3 · PDF-Seite 4
HOS-210450 · Präparat HOS-154523
− Hypersensitivity to the active substances or to any of the excipients listed in section 6.1 − Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis) − Diabetic pre-coma − Severe renal failure (GFR < 30 ml/min) (see section 4.4) − Acute conditions with the potential to alter renal function, such as: - dehydration, - severe infection, - shock, - intravascular administration of iodinated contrast agents (see section 4.4). − Acute or chronic disease which may cause tissue hypoxia, such as: - cardiac or respiratory failure, - recent myocardial infarction, - shock. − Hepatic impairment (see sections 4.2, 4.4 and 4.8) − Acute alcohol intoxication, alcoholism − Breast-feeding (see section 4.6)
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-05T17:36:00Z · SHA-256 6dd842a7717af651a76cb98c459aac61fb2e50cebfa9b433555d63e1a27e92c2 · Passage 056282b5606d0fd250b854d797d139b6618f5a9df5d30228b45b781f0942bf6e · Zeichen 0–833 im Abschnitt